U.S. Securities and Exchange Commission
                             Washington, D.C. 20549

                                   FORM 10-QSB

[X]     QUARTERLY  REPORT  UNDER  SECTION  13  OR  15(d)  OF  THE  SECURITIES
EXCHANGE  ACT  OF  1934  for  the  quarterly  period  ended  June  30,
2000.

[  ]     TRANSITION  REPORT  UNDER  SECTION  13  OR  15(d)  OF  THE  SECURITIES
EXCHANGE ACT OF 1934 for the transition period from _______ to _______

COMMISSION  FILE  NUMBER  001-06-560
                          ----------

                       FAIRCHILD INTERNATIONAL CORPORATION
                 (Name of Small Business Issuer in its Charter)

            Nevada                                         91-1880015
(State or other jurisdiction of             (IRS Employer Identification Number)
 Incorporation or Organization)

          Suite 600, 596 Hornby Street, Vancouver, B.C. Canada V6C 1A4
           (Address of Principal Executive Offices)         (Zip Code)

                                 (604) 646-5614
                           (Issuer's Telephone Number)


Check whether the issuer (1) filed all reports required to be filed by Section13
or  15(d)  of  the  Exchange  Act during the past 12 months (or for such shorter
period  that the registrant was required to file such reports), and (2) has been
subject  to  such  filing  requirements  for  the  past  90  days. Yes [x] No []

The  number  of  shares  of  common  stock  outstanding as of August 14, 2000 is
10,988,210.
-----------


<PAGE>
ITEM  1.  FINANCIAL  INFORMATION

                       FAIRCHILD INTERNATIONAL CORPORATION
                          (A DEVELOPMENT STAGE COMPANY)

                              FINANCIAL STATEMENTS

                                  June 30, 2000

                           (EXPRESSED IN U.S. DOLLARS)




                                    UNAUDITED


<PAGE>
<TABLE>
<CAPTION>
                            FAIRCHILD INTERNATIONAL CORPORATION
                               (A DEVELOPMENT STAGE COMPANY)

                                       BALANCE SHEET

                                       June 30, 2000

                                (EXPRESSED IN U.S. DOLLARS)


ASSETS                                                 2000
                                                    ----------
<S>                                                 <C>
CURRENT
CASH                                                $     106
                                                    ==========

LIABILTIES

CURRENT                                             $  11,190
ACCOUNTS PAYABLE                                       61,205
                                                    ----------
OWING TO RELATED PARTIES
                                                       72,395
                                                    ----------

COMMITMENTS (NOTE 3)

STOCKHOLDERS' EQUITY (DEFICIENCY)

SHARE CAPITAL
AUTHORIZED
     50,000,000 COMMON SHARES WITH A PAR VALUE
                OF $0.001 PER SHARE
      1,000,000 PREFERRED SHARES WITH A PAR VALUE
                OF $0.01 PER SHARE
ISSUED AND FULLY PAID (NOTE 2)
     10,988,210 COMMON SHARES                         894,769

DEFICIT ACCUMULATED DURING THE                       (967,058)
                                                    ----------
DEVELOPMENT STAGE

TOTAL STOCKHOLDERS' DEFICIENCY                        (72,289)
                                                    ----------

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY          $     106
                                                    ==========
</TABLE>

APPROVED  BY  THE  DIRECTOR


---------------------------


                                UNAUDITED


<PAGE>
<TABLE>
<CAPTION>
                       FAIRCHILD INTERNATIONAL CORPORATION
                          (A DEVELOPMENT STAGE COMPANY)

                     STATEMENTS OF OPERARATIONS AND DEFICIT

                 FOR THE SIX MONTHS ENDED JUNE 30, 2000 AND 1999

                           (EXPRESSED IN U.S. DOLLARS)


                                CUMULATIVE
                                    TO        PERIOD ENDED
                                 JUNE 30,       JUNE 30,
                                   2000      2000      1999
                                 --------  --------  --------
<S>                              <C>       <C>       <C>
ADMINISTRATIVE EXPENSES

ADVERTISING                      $  9,008         -         -
BANK CHARGES AND
 FOREIGN EXCHANGE                  12,439       374       971
CONSULTING                         39,267         -       664
OFFICE, RENT AND SECRETARIAL       25,863     6,707    10,535
PROFESSIONAL FEES                  83,248     6,793     5,609
PROMOTION AND TRAVEL              331,040     6,000    69,882
RELATED PARTY
 ADMINISTRATION CHARGES           121,855    12,733    26,477
 CONSULTING FEES                   50,000         -    50,000
RESEARCH AND DEVELOPMENT AND
 LICENSE FEES                     163,520     5,020         -
SHAREHOLDER INFORMATION            19,994     1,972     1,460
TELEPHONE AND UTILITIES             3,440       246     1,020
TRANSFER AGENT FEES                 7,757         -     1,938
                                 --------  --------  --------

                                 $867,431    39,845   168,556

MINERAL INTERESTS AND
 EXPLORATION COSTS                 99,627         -         -
                                 --------  --------  --------

NET LOSS FOR THE PERIOD          $967,058    39,845   168,556
                                 ========

DEFICIT BEGINNING OF THE PERIOD             927,213   456,276
                                           --------  --------

DEFICIT END OF THE PERIOD                  $967,058  $624,832
                                           ========  ========

BASIS LOSS PER SHARE
         PRE STOCK SPLIT                   $   0.01  $   0.25
                                           ========  ========
         POST STOCK SPLIT                  $   0.01  $   0.03
                                           ========  ========
</TABLE>


                              UNAUDITED


<PAGE>
<TABLE>
<CAPTION>

                       FAIRCHILD INTERNATIONAL CORPORATION
                          (A DEVELOPMENT STAGE COMPANY)

                             STATEMENTS OF CASH FLOW

                 FOR THE SIX MONTHS ENDED JUNE 30, 2000 AND 1999

                           (EXPRESSED IN U.S. DOLLARS)


                                        CUMULATIVE
                                            TO            PERIOD ENDED
                                          JUNE 30,          JUNE 30,
                                           2000         2000        1999
                                        -----------  ----------  -----------
<S>                                     <C>          <C>         <C>
CASH PROVIDED (USED) BY
  OPERATING ACTIVITIES
     NET LOSS FOR THE PERIOD             ($967,058)   ($39,845)   ($168,556)
     NON-CASH ITEMS
          ISSUE OF SHARES FOR SERVICES
            AND MINERAL INTEREST           236,858           -            -
       CHANGE IN NON-CASH
         OPERATING ITEM
            ACCOUNTS PAYABLE                11,190       2,985            -
                                        -----------  ----------  -----------

                                          (719,010)    (36,860)    (168,556)
                                        -----------  ----------  -----------
FINANCING ACTIVITIES

       OWING TO RELATED PARTIES             61,205           -       35,432
     SHARE CAPITAL ISSUED FOR CASH         657,911           -      475,000
                                        -----------  ----------  -----------

                                           719,116           -      510,432
                                        -----------  ----------  -----------

CHANGE IN CASH FOR THE PERIOD           $      106     (36,860)     341,876
                                        ===========

CASH BEGINNING OF THE PERIOD                            36,966          595
                                                     ----------  -----------

CASH END OF THE PERIOD                               $     106   $  342,471
                                                     ==========  ===========
</TABLE>


                                   UNAUDITED


<PAGE>
                       FAIRCHILD INTERNATIONAL CORPORATION
                          (A DEVELOPMENT STAGE COMPANY)

                        NOTES TO THE FINANCIAL STATEMENTS

                                  June 30, 2000

1.   ACCOUNTING  POLICES  AND  NOTES

The  accounting  policies  followed  by  the  Company  are  unchanged from those
outlined  in  the  audited  financial statements for the year ended December 31,
1999.  The  notes to the financial statements at December 31, 1999 substantially
apply  to the interim financial statements at June 30, 2000 and are not repeated
here.  All  adjustments  have been made which, in the opinion of management, are
necessary  in  order  to  make  these  financial  statements  not  misleading.

2.   SHARE  CAPITAL
                                                      SHARES       CONSIDERATION
                                                      ------       -------------
     Common  shares  issued  and  fully  paid
     Balance at June 30, 2000 and December 31, 1999   10,988,210      $  894,769
                                                      ==========      ==========

3.   COMMITMENTS

a.  Pharmaceutical  Research  and  Development

The  company  has  entered  into Research, Development and License Agreements to
acquire  an exclusive license to make, use and sell pharmaceutical and processes
relating to arthritis and dermal wrinkles.  The Company has paid $137,520 of the
total  research  and  development  funding  obligation  of  $250,000  and issued
2,600,000  post-split  common  shares  in  consideration  for  the license.  The
balance  of  the  funding obligation is due by October 1, 2000.  The shares have
been  issued  at a nominal value of $.01 per share and are subject to regulatory
restrictions  relating  to their saleability.  A net revenue royalty of 35% will
be  payable  by  the Company on revenue for licensed products.  The agreement is
with  a  company  formerly  under  common  management.

b.  Consulting  Agreement

The  Company  entered  into  a  consulting  agreement with a former director for
public  relations  services  for  a  twelve-month  period to March 15, 2000.  As
consideration  for  the  services,  the  Company:

-  paid  cash  of  $25,000;
-  issued  500,000  post-split (50,000 pre-split) shares at an ascribed value of
   $.50  per  shares;
-  granted options to acquire to March 15, 2000 (lapsed without being exercised)
   500,000 post-split common shares at $.05 and 500,000 post-split common shares
   at $.15;  and
-  granted an option to acquire up to 5% of the outstanding common shares of the
   Company when  these  shares qualify for the NASDAQ small cap over the counter
   public trading at $.50 per share for a period of  two  years from the date of
   the listing.

As  of  June 30, 2000, the  exercise price of outstanding stock options exceeded
the  quoted  market  value  of  the  shares.  Accordingly,  no  stock  option
compensation  has  been  recognized  in  the  financial  statements.


<PAGE>
ITEM  2.  PLAN  OF  OPERATION
With  the  exception of historical facts stated herein, the matters discussed in
this  report  are  "forward  looking"  statements  that  involve  risks  and
uncertainties  that  could  cause  actual  results  to  differ  materially  from
projected  results.  Such  "forward  looking"  statements  include,  but are not
necessarily  limited  to,  statements  regarding  anticipated  levels  of future
revenues and earnings from operations of the Company. Readers of this report are
cautioned  not to put undue reliance on "forward  looking" statements which are,
by  their  nature,  uncertain  as reliable indicators of future performance. The
Company  disclaims  any  intent  or obligation to publicly update these "forward
looking"  statements,  whether as a result of new information, future events, or
otherwise.

We  eventually  plan  to  develop  specialized e-commerce sites on the Internet.
Over  the  next  twelve  months,  we plan to focus on development of an Internet
portal  for alternative health care products.  We hope that this site will offer
our  products,  as  well  as  those of other companies.  In addition, we plan to
offer  information  on  related  topics  on  the  website.


<PAGE>
In  the  past, we have relied upon funding from our former officer and director,
Mr.  David  Stadnyk.  We  borrowed  approximately  $44,000  from  Mr.  Stadnyk
during  our  development  stage,  $40,000  of  which  has  been  repaid.  We are
currently  unable  to  satisfy  our  cash  requirements  without  the  financial
support  of our President, Byron  Cox,  or  his  designee.  We  anticipate  that
we  will  meet  our  cash  requirements  for  the  next  twelve  months  through
Mr.  Cox's  financial support, even  though  Mr.  Cox  has  not  supplied  funds
to  the  Company  in  the  past.  Currently,  we  have no commitment for funding
from  our  past  or  present  officers  and  directors  or  any  other  party.

Eventually,  we will need to raise additional funds,  if we plan to implement an
advertising  and  marketing  plan  to  advance  our website.  We  have  not  yet
determined  how  we  plan  to  obtain  these  additional  funds.

In  1999,  we raised cash proceeds of $475,000 from the sale of our common stock
to business associates and friends of Mr. Standyk and Mr. Cox.  These funds were
for  general  operating expenses.  At the time these funds were raised they were
not intended for the Praxis Pharmaceuticals licensing agreement. In this regard,
we  issued  3,000,000  shares  for  $150,000  on  March  15,  1999 and we issued
1,000,000 shares on April 1, 1999 for $300,000.   The proceeds are to be used to
implement  our new plan of business.

Since we have entered into an agreement with Praxis Pharmaceuticals for research
and development, we will encounter significant research and development expenses
over  the  next  twelve  months.  In  addition  to  the  terms  of  the  Praxis
Pharmaceuticals  agreement,  we  may  seek  to  conduct  other  research  and
development,  which  would  result  in  expenses  beyond  those  outlined in the
agreement  with  Praxis  Pharmaceuticals.

Our  goal  is  to  have Praxis Pharmaceuticals provide us with products that are
ready  for  market.  The  first  product  that  we  hope  to receive from Praxis
Pharmaceuticals  is  the  anti-wrinkle compound while the second is an arthritis
product.

Since we outsource most of our operations, we do not anticipate establishing our
own  manufacturing  facilities  over  the  next twelve months.  Beyond this time
frame,  we  plan to make a decision with regard to purchase or sale of any plant
and  significant equipment in the long term after products are introduced to the
public  through  our  website,  if  ever.  As  conditions  dictate,  we  will
engage  additional employees.  We do not plan to make  any  significant  changes
in  the  number  of  employees  over  the  next  twelve  months.

Item  3.  Defaults  Upon  Senior  Securities
None.

Item  4.  Submission  of  Matters  to  a  Vote  of  Security  Holders
None.

Item  5.  Other  Information
None.

Item  6.  Exhibits  and  Reports  on  Form  8-K
None.

SIGNATURES

In  accordance  with  the  requirements  of  the  Securities  Exchange  Act
of  1934,  the  registrant  has  duly  caused  this  report  to  be  signed  on
its  behalf  by  the  undersigned,  thereunto  duly  authorized.


Dated:  8/14/00                       By:  /s/  Byron  Cox
                                      ---------------------
                                      Byron  Cox,  President  and  Director


<PAGE>


Vancouver,  Canada
August  2,  2000